Abbott Laboratories (ABT) — Technical state
As of 2026-11-05 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Signal: Bullish stack, 200-day still turning — Trades +9.3% vs the 50-day and +12.2% vs the 200-day average, 13% below the 52-week high and +38.6% off the 52-week low; a golden cross printed 39 sessions ago. Computed from daily closes. (as of 2026-11-05)
- Trend: Abbott Laboratories trades 9.3% above its 50-day and 12.2% above its 200-day moving average. (as of 2026-11-05)
Abbott Laboratories operates across four segments: established pharmaceutical products, diagnostic products, nutritional products, and medical devices. It makes generic drugs, diagnostic testing systems for laboratories and point-of-care settings, infant and adult nutrition products, and devices for cardiovascular disease, diabetes monitoring and neuromodulation.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ABT overview. Research diary readings, not advice.
Trades +9.3% vs the 50-day and +12.2% vs the 200-day average, 13% below the 52-week high and +38.6% off the 52-week low; a golden cross printed 39 sessions ago. Computed from daily closes.
The moving-average stack
- vs 20-day+8.3%
- vs 50-day+9.3%
- vs 200-day+12.2%
- 52-week band13% off the high · +38.6% off the low
- Streak1 consecutive down session
- CrossoverGolden cross 39 sessions ago
- 50-day crossprice crossed up through the 50-day 5 sessions ago
- Stochastic%K 82.1 · %D 94.8 · bear cross
Continue: the ABT chart & overview · the signal board
FAQ · from the current data · as of 2026-11-05
Quick answers
What is the current Closelooknet signal on ABT?
Bullish stack, 200-day still turning — Trades +9.3% vs the 50-day and +12.2% vs the 200-day average, 13% below the 52-week high and +38.6% off the 52-week low; a golden cross printed 39 sessions ago. Computed from daily closes. As of 2026-11-05; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is ABT above its 50-day and 200-day moving averages?
As of 2026-11-05, Abbott Laboratories trades +9.3% above its 50-day and +12.2% above its 200-day average, with the 20-day +8.3% away.
How far is ABT from its 52-week high?
13% below the 52-week high and 38.6% above the 52-week low, as of 2026-11-05.
Mentioned on Closelooknet
Where ABT appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Long reads
- Covered Calls for Income — the Dividend Aristocrats Approach
The list overlaps heavily with the consumer-staples / industrials / healthcare slow-compounders: KO, PG, JNJ, KMB, MMM, ED, ABT, MMC, EMR, ITW, and on.
Related in the Closelooknet universe
then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- DXCM DexCom Incindustry
- CEVI.ST CellaVision ABindustry
- GMED Globus Medicalindustry
- SECT-B.ST Sectra AB (publ)industry
- SNN Smith & Nephew SNATS Incindustry
- SOON.SW Sonova H Agindustry
- ENOV Enovis Corpindustry
- PACB Pacific Biosciences of Californiaindustry
- MED.SW Medartis Holding AGindustry
- PHG Koninklijke Philips NV ADRindustry
- DEMANT.CO Demant A/Sindustry
- STE STERIS plcindustry
- LIVN LivaNova PLCindustry
- AXGN Axogen Incindustry
- EW Edwards Lifesciences Corpindustry
- MDT Medtronic PLCindustry
- IRTC iRhythm Technologies Incindustry
- ZBH Zimmer Biomet Holdings Incindustry
- CNMD CONMED Corporationindustry
- HAE Haemonetics Corporationindustry